文献速递性腺与生殖内分泌糖尿病

CAIS睾丸分子通路揭示睾酮/雌二醇比值与非梗阻性无精症生殖细胞肿瘤风险相关

Testis Molecular Pathways in CAIS Unveil Testosterone/Estradiol on Germ Cell Tumor Risk in Non-Obstructive Azoospermia.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

本研究对一例完全雄激素不敏感综合征(CAIS)患者睾丸体细胞进行单细胞RNA测序,并与正常生精、非梗阻性无精症(NOA)、Klinefelter综合征(KS)及睾丸生殖细胞癌数据集整合。分析年龄匹配男性(120例生育、155例不育、116例NOA、18例KS、343例TGCC)的睾酮和雌二醇水平,发现NOA中 Leydig 细胞表达与精原细胞瘤微环境相关的转录本,且睾酮/雌二醇比值下降对非遗传性NOA男性TGCC具有预后作用。

要点

  • NOA患者Leydig细胞呈未成熟和衰老状态,且与原发性性腺功能减退相关的NOA表达最高水平的精原细胞瘤微环境相关转录本。
  • Leydig细胞的肿瘤转录特征在系统水平得到证实:睾酮/雌二醇比值下降对非遗传性NOA男性TGCC具有预后作用。
  • 研究提示可通过分子通路预测NOA患者TGCC风险,并可能为芳香化酶抑制剂的使用提供依据。

核心结论

  • 在NOA中,Leydig细胞表达与精原细胞瘤微环境相关的转录本,包括雌激素反应基因,且睾酮/雌二醇比值下降对非遗传性NOA男性TGCC具有预后作用。
  • 本研究为NOA患者TGCC的预测及芳香化酶抑制剂的使用资格提供了分子见解。

研究设计与样本

  • 对一例CAIS患者睾丸体细胞进行单细胞RNA测序,并与已发表的正常生精、NOA、KS和睾丸生殖细胞癌的scRNA-seq数据集整合。
  • 分析年龄匹配男性(120例生育、155例不育、116例NOA、18例KS、343例TGCC)的睾酮和雌二醇水平。

主要发现

  • 在所有条件下,Leydig细胞均未成熟和衰老,但与原发性性腺功能减退相关的NOA中Leydig细胞表达最高水平的精原细胞瘤微环境相关转录本,包括雌激素反应基因。
  • Leydig细胞的肿瘤转录特征在系统水平得到证实:睾酮/雌二醇比值下降对非遗传性NOA男性TGCC具有预后作用。

临床怎么用

  • 对于非遗传性NOA男性,可关注睾酮/雌二醇比值以评估TGCC风险。
  • 研究提示芳香化酶抑制剂可能适用于部分NOA患者,但需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Non-obstructive azoospermia (NOA) is the most severe form of male infertility, affecting 1% of all men, with a clinical picture characterized by no sperm production, hyalinization of the basal membrane of the seminiferous tubules, primary hypogonadism, and earlier onset of age-related comorbidities compared with fertile men. NOA is also characterized by etiologic heterogeneity and the non-genetic form has higher incidence of testicular germ cell cancer (TGCC) compared to the forms with genetic abnormalities. OBJECTIVE: We aimed to establish molecular pathways in the testicular somatic cells that are either shared or specific for non-genetic and genetic forms of NOA, such as complete androgen insensitivity syndrome (CAIS) and Klinefelter syndrome (KS). METHODS: We performed single-cell RNA sequencing of the testicular somatic cells of an individual with CAIS, and data integration with published scRNA-seq datasets of testis with normal spermatogenesis, NOA, KS, and germinal testicular cancer. Detailed clinical data of the CAIS patient, testosterone and estradiol levels in age-matched men (120 fertile, 155 infertile, 116 NOA, 18 KS, and 343 with TGCC) were analyzed. RESULTS: In all conditions, Leydig cells are immature and senescent, but those of NOA associated with primary hypogonadism depict the highest expression of transcripts associated with the seminoma microenvironment, including estrogen-responsive genes. An oncological transcriptional signature in the Leydig cells has been confirmed at the systemic levels by showing a prognostic role of the decreasing testosterone/estradiol ratio for TGCC in men with non-genetic NOA. CONCLUSION: This study offers molecular insights into the prediction of TGCC in persons with NOA and eligibility for the use of aromatase inhibitors.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Alfano M, Tascini AS, Pederzoli F, et al. Testis Molecular Pathways in CAIS Unveil Testosterone/Estradiol on Germ Cell Tumor Risk in Non-Obstructive Azoospermia. J Clin Endocrinol Metab. 2026. PMID: 40658795. doi:10.1210/clinem/dgaf404

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。